Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caspofungin vs Micafungin in Japanese Patients with Deep-seated Fungal Infections
NCT00717860Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Aug 2008
- Primary completion
- Jul 2010
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
01
Overview
A Phase 3 trial of caspofungin in esophageal candidiasis, invasive candidiasis, aspergillosis, sponsored by Merck & Co.. Started Aug 2008; status: completed.
02
Drugs
caspofungin
03
Conditions
esophageal candidiasisinvasive candidiasisaspergillosis
Beyond the preview
Go deeper on NCT00717860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00717860.